Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes.

Pharmacological research
Q1
Mar 2020
Citations:48
Influential Citations:1
Interventional (Human) Studies
87
S2 Icon

Abstract

No abstract available